Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

Lancet Neurology

Volumn 6, Issue 9, 2007, Pages 773-781

  Banwell, Brenda ^a,b   Krupp, Lauren ^c   Kennedy, Julia ^a,b   Tellier, Raymond ^a   Tenembaum, Silvia ^d   Ness, Jayne ^e   Belman, Anita ^c   Boiko, Alexei ^f   Bykova, Olga ^f   Waubant, Emmanuelle ^g   Mah, Jean K ^h   Stoian, Cristina ^h   Kremenchutzky, Marcelo ⁱ   Bardini, Maria Rita ^j   Ruggieri, Martino ^k   Rensel, Mary ^l   Hahn, Jin ^m   Weinstock Guttman, Bianca ⁿ   Yeh, E Ann ⁿ   Farrell, Kevin ^o   Freedman, Mark ^p   Iivanainen, Matti ^q   Sevon, Meri ^q   Bhan, Virender ^r   Dilenge, Marie Emmanuelle ^s   Stephens, Derek ^a,b   Bar Or, Amit ^t   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e University of Alabama at Birmingham   (United States)

^f PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ London Health Sciences   (Canada)

^j UNIVERSITY OF FLORENCE   (Italy)

^k UNIVERSITY OF CATANIA   (Italy)

^l LERNER RESEARCH INSTITUTE   (United States)

^m STANFORD UNIVERSITY   (United States)

ⁿ STATE UNIVERSITY OF NEW YORK   (United States)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p UNIVERSITY OF OTTAWA   (Canada)

^q UNIVERSITY OF HELSINKI   (Finland)

^r DALHOUSIE UNIVERSITY   (Canada)

^s MONTREAL CHILDREN S HOSPITAL   (Canada)

^t MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE DURATION; ENCEPHALOMYELITIS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; ONSET AGE; OPTIC NEURITIS; PARVOVIRUS; PHYSICAL DISABILITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SEROLOGY; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CASE-CONTROL STUDIES; CHILD; DEMOGRAPHY; DISABILITY EVALUATION; ECONOMICS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MULTIPLE SCLEROSIS; OBSERVATION; PEDIATRICS; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; SIMPLEXVIRUS;

EID: 34547754534     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70196-5     Document Type: Article

References (59)

1. Mikaeloff Y., Suissa S., Vallee L., et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 144 (2004) 246-252
2. Mikaeloff Y., Caridade G., Assi S., Suissa S., and Tardieu M. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics 118 (2006) 1133-1139
3. Ghezzi A., Deplano V., Faroni J., et al. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 3 (1997) 43-46
4. Ghezzi A., Pozzilli C., Liguori M., et al. Prospective study of multiple sclerosis with early onset. Mult Scler 8 (2002) 115-118
5. Banwell B. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 4 (2004) 245-252
6. Simone I., Carrara D., Tortorella C., et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 59 (2002) 1922-1928
7. Belopitova L., Guergueltcheva P., and Bojinova V. Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings. J Child Neurol 16 5 (2001) 317-324
8. Chiemchanya S., and Visudhiphan P. Multiple sclerosis in children: a report of 17 Thai pediatric patients. J Med Assoc Thai 76 suppl 2 (1993) 28-33
9. Deryck O., Ketelaer P., and Dubois B. Clinical characteristics and long term prognosis in early onset multiple sclerosis. J Neurol 253 (2006) 720-723
10. Guilhoto L., Osorio C., Machado L., et al. Pediatric multiple sclerosis report of 14 cases. Brain Dev 17 (1995) 9-12
11. Mattyus A., and Veres E. Multiple sclerosis in childhood: long term katamnestic investigations. Acta Paediatr Hung 26 (1985) 193-204
12. Shiraishi K., Higuchi Y., Ozawa K., Hao Q., and Saida T. Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan. Brain Dev 27 (2005) 224-227
13. Pugliatti M., Sotgiu S., and Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104 (2002) 182-191
14. Dean G., and Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63 (1997) 565-568
15. Pugliatti M., Riise T., Sotgiu M., et al. Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. Am J Epidemiol 164 (2006) 326-333
16. Ascherio A., and Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 11 (2000) 220-224
17. Ascherio A., Munger K., Lennette E., et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286 (2001) 3083-3088
18. Buljevac D., van Doornum G., Flach H., et al. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76 (2005) 1377-1381
19. Bray P., Bloomer L., Salmon V., Bagley M., and Larsen P. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 40 (1983) 406-408
20. Larsen P., Bloomer L., and Bray P. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 35 (1985) 435-438
21. Delorenze G., Munger K., Lennette E., Orentreich N., Vogelman J., and Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63 (2006) 839-844
22. Haahr S., and Hollsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 16 (2006) 297-310
23. Alotaibi S., Kennedy J., Tellier R., Stephens D., and Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291 (2004) 1875-1879
24. Pohl D., Krone B., Rostasy K., et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67 (2006) 2063-2065
25. Poser C., Paty D., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
26. McDonald W., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
27. Tenembaum S., Chamoles N., and Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59 (2002) 1224-1231
28. Krupp L., Banwell B., Tenembaum S., and for the International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis. Neurology 68 (2007) S7-S12
29. Wingerchuk D., Lennon V., Pittock S., Lucchinetti C., and Weinshenker B. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489
30. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
31. Uitdehaag B., Kappos L., Bauer L., et al. Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization. Mult Scler 11 (2005) 227-231
32. Lucchinetti C., Kiers L., O'Duffy A., et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49 (1997) 1413-1418
33. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59 (2002) 499-505
34. Cepok S., Zhou D., Srivastava R., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115 (2005) 1352-1360
35. Sundstrom P., Juto P., Wadell G., et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62 (2004) 2277-2282
36. Gluckman P., and Hanson M. Evolution, development and timing of puberty. Trends Endocrinol Metab 17 (2006) 7-12
37. Schwarz S., Mohr A., Knauth M., Wildemann B., and Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56 (2001) 1313-1318
38. O'Connor K., McLaughlin K., De Jager P., et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13 (2007) 211-217
39. O'Connor P. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology 59 6 suppl 3 (2002) S1-S33
40. Bar-Or A., and Smith D. Epidemiology of multiple sclerosis. In: Batchelor T., and Cudcowicz M. (Eds). Textbook of neuroepidemiology (2001), Butterworth Heinemann, Woburn, MA, USA
41. Banwell B., and Anderson P. The cognitive burden of multiple sclerosis in children. Neurology 64 (2005) 891-894
42. MacAllister W., Belman A., Milazzo M., et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 64 (2005) 1422-1425
43. Mikaeloff Y., Moreau T., Debouverie M., et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 139 (2001) 443-446
44. Banwell B., Reder A., Krupp L., et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 66 (2006) 472-476
45. Waubant E., Hietpas J., Stewart T., et al. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 32 (2001) 211-213
46. Etheridge L., Beverley D., Ferrie C., and McManus E. The use of interferon beta in relapsing-remitting multiple sclerosis. Arch Dis Child 89 (2004) 789-791
47. Kornek B., Bernert G., Balassy C., Geldner J., Prayer D., and Feucht M. Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 34 (2003) 120-126
48. Ghezzi A., Amato M., Capobianco M., et al. Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler 11 (2005) 420-424
49. Pohl D., Rostasy K., Gartner J., and Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 64 (2005) 888-890
50. Tenenbaum S., Martin S., and Fejeman N. Disease-modifying therapies in childhood and juvenile multiple sclerosis. Mult Scler 7 (2001) S57
51. Wandinger K.-P., Jabs W., Siekhaus S., et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55 (2000) 178-184 2000
52. Baboonian C., Venables P., Williams D., Williams R., and Maini R. Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis 50 (1991) 772-775
53. Levitskaya J., Coram M., Levitsky V., et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 (1995) 685-688
54. Rhodes G., Carson D., Valbracht J., Houghten R., and Vaughan J. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 134 (1985) 211-216
55. Martin J. Herpes simplex virus types 1 and 2 and multiple sclerosis. Lancet 2 (1981) 777-781
56. Ponsonby A., van dM I., Dwyer T., et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 293 (2005) 463-469
57. Tejada-Simon M., Zang Y., Hong J., Rivera V., and Zhang J. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53 (2003) 189-197
58. Swanborg R., Whittum-Hudson J., and Hudson A. Infectious agents and multiple sclerosis-are Chlamydia pneumoniae and human herpes virus 6 involved?. J Neuroimmunol 136 (2003) 1-8
59. Rostasy K., Reiber H., Pohl D., et al. Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Neurology 61 (2003) 125-128